Discontinuation of cholinesterase inhibitor treatment in institutionalised patients with advanced dementia | European Journal of Hospital Pharmacy

Subscribe
Log In More

Log in via Institution
Log in via OpenAthens
Log in via EAHP

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Current issue

Archive

Authors

About
Subscribe
Log in More

Log in via Institution
Log in via OpenAthens
Log in via EAHP

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals

Article metrics

Original research

Discontinuation of cholinesterase inhibitor treatment in institutionalised patients with advanced dementia

Online download statistics by month:

Online download statistics by month: July 2020 to March 2024

	Abstract	Full	Pdf
Jul 2020	785	8	3
Aug 2020	587	3	2
Sep 2020	307	5	3
Oct 2020	136	1	2
Nov 2020	132	1	2
Dec 2020	79	0	0
Jan 2021	97	1	1
Feb 2021	89	3	3
Mar 2021	74	1	0
Apr 2021	71	0	1
May 2021	58	1	1
Jul 2021	1	1	0
Aug 2021	3	0	0
Sep 2021	1	1	0
Oct 2021	148	2	1
Nov 2021	175	1	0
Dec 2021	160	0	2
Jan 2022	167	0	0
Feb 2022	184	0	0
Mar 2022	189	0	0
Apr 2022	389	5	1
May 2022	604	11	7
Jun 2022	463	13	10
Jul 2022	111	4	3
Aug 2022	107	0	0
Sep 2022	93	1	1
Oct 2022	151	4	3
Nov 2022	100	1	1
Dec 2022	93	0	1
Jan 2023	92	5	2
Feb 2023	121	1	1
Mar 2023	167	4	0
Apr 2023	200	1	4
May 2023	106	0	0
Jun 2023	48	1	0
Jul 2023	59	0	0
Aug 2023	34	1	0
Sep 2023	53	0	0
Oct 2023	51	0	0
Nov 2023	61	1	0
Dec 2023	47	1	2
Jan 2024	64	0	2
Feb 2024	64	1	0
Mar 2024	72	0	0
Total	6793	84	59